Pacira Biosciences
PCRX
#5836
Rank
$1.07 B
Marketcap
$23.99
Share price
0.04%
Change (1 day)
24.49%
Change (1 year)
Categories

Revenue for Pacira Biosciences (PCRX)

Revenue in 2025 (TTM): $0.71 Billion USD

According to Pacira Biosciences 's latest financial reports the company's current revenue (TTM ) is $0.71 Billion USD. In 2024 the company made a revenue of $0.70 Billion USD an increase over the revenue in the year 2023 that were of $0.67 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacira Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.71 B2.26%
2024 $0.70 B3.85%
2023 $0.67 B1.22%
2022 $0.66 B23.14%
2021 $0.54 B26.04%
2020 $0.42 B2.05%
2019 $0.42 B24.83%
2018 $0.33 B17.67%
2017 $0.28 B3.71%
2016 $0.27 B10.99%
2015 $0.24 B25.97%
2014 $0.19 B131.05%
2013 $85.55 M118.89%
2012 $39.08 M149.13%
2011 $15.68 M7.73%
2010 $14.56 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Recro Pharma
REPH
$75.36 M-89.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
$0.10 B-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
$7.13 M-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
$0.15 B-78.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
$81.69 M-88.60%๐Ÿ‡บ๐Ÿ‡ธ USA